Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Stomach Neoplasms 2TAS 102 1Sarcoma, Ewing 1Sarcoma 1Osteosarcoma 1Neoplasms 1Colorectal Adenocarcinoma 1Colonic Neoplasms 1Bone Neoplasms 1

Interventions

regorafenib 1HMPL-013 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × TAS 102 × HMPL-013 × Clear all
NCT05993702 2023-08-15

TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer

China Medical University, China

Unknown
45 enrolled
Gastrointestinal

TAS 102

Data powered by HemOnc (CC BY 4.0) Colophon âš¡